Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam versus propofol for prevention of postoperative delirium after bronchoscopy in elderly patients
ChiCTR2400087354Phase 4Not yet recruiting
- Sponsor
- Zaozhuang Municipal Hospital
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in postoperative delirium (POD) (2 arms), sponsored by Zaozhuang Municipal Hospital. Primary endpoints: Postoperative delirium, Vital signs (blood pressure, blood oxygen saturation, heart rate, respiratory rate) and 1 more. Planned start Jul 2024; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on ChiCTR2400087354.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400087354.